Vilazodone as a medication for depression - discussion
Vilazodone (trade name Viibryd) is a serotonergic antidepressant developed by Clinical Data for the treatment of major depressive disorder. The chemical compound was originally developed by Merck KGaA (Germany). Vilazodone was approved by the FDA for use in the United States to treat major depressive disorder in 2011. More: en.wikipedia.org.
0 opinions, 0 replies
Add your opinion:
Challenge someone to answer this topic:
Invite an OpiWiki user:
OR
Invite your friend via email:
@
click for template
OR
Share it:
Share this discussion via OpiWiki smartlink:
OR